PRC
SGYP

Platte River Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Platte River Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$103K Buy
+19,400
New +$150K 0.09% 115

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Platte River Capital's SGYP Position: Q3 2015 in Review

Platte River Capital opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2015: 19,400 shares worth $103K. The stake represents 0.09% of the portfolio and ranks #115 among its holdings.

129 funds tracked by Wall St. Rank hold SGYP as of Q3 2015.

  • Platte River Capital held 19,400 shares of Synergy Pharmaceuticals, Inc Common Stock worth $103K as of Q3 2015.
  • Synergy Pharmaceuticals, Inc Common Stock was a new Platte River Capital position in Q3 2015.
  • Synergy Pharmaceuticals, Inc Common Stock made up 0.09% of Platte River Capital's portfolio in Q3 2015, its #115 holding.
  • 129 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.